Im personally a little disappointed because it seems that there were some people who couldn't even maintain on CB and this drug will not even be available for at least 5 more years. We deserve something better already for gods sake. I really hope SM will amaze us..
yes, 6 worsened. And what if they had an effluvium?
What I miss in this slideset is the hair caliber. With such a small sample, I would not care about hair count
[*] but by calibers.
If some of the worsened patients had some effluvium but the caliber of remaining shafts has improved on average, it would be a sign of effectiveness.
[*] hair count is made by vellus hair turned into non-vellus hair, but also but a new growth after an effluvium, or a loss by the onset of an effluvium. We need very large numbers to rule out these ripples. But large numbers mean big costs, and this was a PoC. And, guess what, finasteride clinical studies always had big numbers afaik (100+ patients).
P.S. just to give an example of what a bad statistics is, look at the placebo group: 15 out of 25 patients (8 NW3, 8 NW4, 9 NW5!) maintained or improved over 6 months with just a vehicle. It's 60%... I mean, if I am in such an advanced stage of male pattern baldness and I can apply such a good vehicle and have more than 1 out of 2 chances to maintain or improve... well, just don't wait for 2022 and sell me that vehicle right away!
Also check at the Norwood distribution for the 3 groups. Slight variations in favour of minoxidil... but small numbers matter a lot in small samples, and build bad statistics.
So, again: a PoC is not made to generate statistically significant data.